Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Aptus Pharma Ltd. Share Price
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹421.40 |
|---|---|
| Day's Range | ₹395.00 - ₹421.55 |
| Open | ₹403.50 |
| 52 Week Range | ₹34.80 - ₹421.55 |
| Volume | 30,400 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 125.74 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 156.43 |
| TTM EPS (₹) | 2.69 |
| P/E Ratio | 20.74 |
| Book Value(₹) | 21.49 |
| PAT Margin (%) | 9.66 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 30.01 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | N/A | 245.58 |
| Expenses | N/A | N/A |
| PBT | N/A | 41.95 |
| Operating profit | N/A | 0.0 |
| Net profit | N/A | 31.0 |
About Aptus Pharma Ltd.
| Founded | 2010 |
|---|---|
| Managing Director | Tejash Maheshchandra Hathi |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Adani Enterprises Ltd. | 3,56,448.70 | 2,633.10 | 1,753.00 - 1,753.00 |
| Aditya Infotech Ltd. | 51,332.25 | 4,186.05 | 0.00 - 0.00 |
| Aegis Logistics Ltd. | 48,722.31 | 1,385.55 | 576.10 - 576.10 |
| Premier Energies Ltd. | 40,628.66 | 895.00 | 660.00 - 660.00 |
| Redington Ltd. | 29,715.25 | 379.60 | 191.31 - 191.31 |
| Honasa Consumer Ltd. | 15,282.39 | 467.00 | 248.40 - 248.40 |
| Lloyds Enterprises Ltd. | 11,273.09 | 73.70 | 40.69 - 40.69 |
| SG Mart Ltd. | 9,785.89 | 779.45 | 313.10 - 313.10 |
| MMTC Ltd. | 8,239.50 | 54.96 | 50.10 - 50.10 |
| Cello World Ltd. | 8,238.91 | 365.30 | 314.00 - 314.00 |
No Records Found
Latest News
Aptus Pharma informs about analyst meet
Pursuant to the provisions of Regulation 30 of Listing Regulations, Aptus Pharma has informed that the management of the Company will be participating in Arihant Capital: Bharat Connect Conference - Rising Stars on Friday, September 25, 2026 at 3:00 - 4:00 pm. Discussions will be based on publicly available information.
The above information is a part of company’s filings submitted to BSE.
Aptus Pharma informs about confirmation certificate
SRU Steels - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 0.00 | 231.63 | 0.00 | 0.00 | 231.63 | 0.00 | 304.05 | 253.44 | 19.97 |
| Other Income | 0.00 | 0.46 | 0.00 | 0.00 | 0.46 | 0.00 | 2.12 | 2.64 | -19.70 |
| PBIDT | -0.56 | 17.14 | -103.27 | -0.56 | 17.14 | -103.27 | -6.59 | -4.01 | 64.34 |
| Interest | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | -0.56 | 17.13 | -103.27 | -0.56 | 17.13 | -103.27 | -6.59 | -4.01 | 64.34 |
| Depreciation | 0.11 | 0.19 | -42.11 | 0.11 | 0.19 | -42.11 | 0.63 | 0.57 | 10.53 |
| PBT | -0.67 | 16.94 | -103.96 | -0.67 | 16.94 | -103.96 | -7.22 | -4.58 | 57.64 |
| TAX | 0.00 | 3.47 | 0.00 | 0.00 | 3.47 | 0.00 | -0.02 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 | 0.00 | -0.03 | 0.00 | 0.00 |
| PAT | -0.67 | 13.47 | -104.97 | -0.67 | 13.47 | -104.97 | -7.20 | -4.58 | 57.21 |
| Equity | 599.39 | 599.39 | 0.00 | 599.39 | 599.39 | 0.00 | 599.39 | 599.39 | 0.00 |
| PBIDTM(%) | 0.00 | 7.40 | 0.00 | 0.00 | 7.40 | 0.00 | -2.17 | -1.58 | 36.99 |
StarlinePS Enterprises informs about certificate
Surat Trade and Mercantile informs about newspaper publication
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Aptus Pharma Ltd. is ₹421.40 as of 2026-10-09.
The market capitalisation of Aptus Pharma Ltd. is ₹722.70 as of 2026-10-09.
The 1-year return of Aptus Pharma Ltd. is 387.13% as of 2026-10-09.
The P/E ratio of Aptus Pharma Ltd. is 20.74 as of 2026-10-10.
The 52-week high and low of Aptus Pharma Ltd. are ₹421.55 and ₹34.80, respectively, as of 2026-10-09.
People Also Ask
Aptus Pharma Ltd. is an Indian pharmaceutical company that markets and distributes finished pharmaceutical formulations. The company follows an asset-light model and works with external manufacturing partners.
Aptus Pharma Ltd. manages pharmaceutical product brands and handles their marketing and distribution. It sources medicines from contract manufacturers and supplies products across acute, chronic and wellness categories.
Aptus Pharma Ltd. was incorporated on 12 August 2010. It initially operated as a private limited company and later became a public limited company.
The company’s registered office is in Aslali, Ahmedabad, Gujarat. It also has corporate offices in Rajkot, Gujarat.
Aptus Pharma Ltd. operates in the pharmaceutical industry. Its business covers the marketing and distribution of finished pharmaceutical formulations.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
